Latest News for: schizophrenia

Edit

Minerva Neurosciences Announces FDA Recommendation for Type C Meeting to Discuss Evidence for Use of Roluperidone as Monotherapy for the Treatment of Negative Symptoms in Patients with Schizophrenia in Advance of Potential NDA Submission (Minerva Neurosciences Inc)

Public Technologies 03 Nov 2021
Minerva Neurosciences Announces FDA Recommendation for Type C Meeting to Discuss Evidence for Use of Roluperidone as Monotherapy for the Treatment of Negative Symptoms in Patients with Schizophrenia in Advance of Potential NDA Submission ... for the treatment of the negative symptoms of schizophrenia.
Edit

"I Want to Live A Life That's Not Defined By My Schizophrenia" (Johnson & Johnson)

Public Technologies 03 Nov 2021
Around the world, 20 million adults are living with schizophrenia, a chronic brain disorder that can lead to symptoms including delusions, hallucinations, trouble with thinking and lack of motivation ... Eventually, I was diagnosed with paranoid schizophrenia ... When you have schizophrenia, finding a medication that works for you is a game-changer.
Edit

Phase 3 Data of mdc-IRM, First Product Based On MedinCell’s Technology, Shows Significant Improvements in Patients With Schizophrenia:

Pharmiweb 01 Nov 2021
-         Prolonged time to impending relapse ... MONTPELLIER, France--(BUSINESS WIRE)--Developed in collaboration with Teva Pharmaceuticals, mdc-IRM, a risperidone extended-release injectable suspension for the treatment of patients with schizophrenia (Teva codename ... by Teva, provided marketing authorization ... .
Edit

Phase 3 Data of mdc-IRM, First Product Based On MedinCell’s Technology, Shows Significant Improvements in ...

Courier Express 01 Nov 2021
MONTPELLIER, France--(BUSINESS WIRE)--Nov 1, 2021--. Developed in collaboration with Teva Pharmaceuticals, mdc-IRM, a risperidone extended-release injectable suspension for the treatment of patients with schizophrenia (Teva codename. TV-46000), is the most advanced investigational product based on MedinCell’s BEPO ® technology ... About MedinCell ... SOURCE.
Edit

Phase 3 data of mdc-IRM, first product based on MedinCell’s technology, shows significant improvements in patients with schizophrenia: Prolonged time to impending relapse / Decreased risk of relapse / Increased chance of clinical stability11.01.2021 (Medincell SA)

Public Technologies 01 Nov 2021
Phase 3 data of mdc-IRM, first product based on MedinCell's technology, shows significant improvements in patients with schizophrenia ... Developed in collaboration with Teva Pharmaceuticals, mdc-IRM, a risperidone extended-release injectable suspension for the treatment of patients with schizophrenia (Teva codename ... Schizophrenia.
Edit

Phase 3 Data of mdc-IRM, First Product Based on MedinCell’s Technology, Shows Significant Improvements in Patients With Schizophrenia (Medincell SA)

Public Technologies 01 Nov 2021
) Phase 3 Data of mdc-IRM, First Product Based on MedinCell's Technology, Shows Significant Improvements in Patients With Schizophrenia ... Developed in collaboration with Teva Pharmaceuticals, mdc-IRM, a risperidone extended-release injectable suspension for the treatment of patients with schizophrenia (Teva codename ... Schizophrenia.
Edit

A Very Jewish Habbening Halloween Special (Schizophrenia Academia)

Bitchute 31 Oct 2021
Go to the source via the article link to view the video ....
Edit

He was diagnosed with schizophrenia in ICE custody. A decade later, he's stuck in the ...

The Arizona Republic 30 Oct 2021
Detention often is the first line of treatment for people who don't have access to care, and then many end up stuck in a complex legal system ... .
Edit

New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Time to Impending Relapse Compared to Placebo in Patients with Schizophrenia (Teva Pharmaceutical Industries Ltd)

Public Technologies 30 Oct 2021
New data showed TV-46000 decreased risk of relapse and increased chance of clinical stability versus placebo in patients with schizophrenia ... "When managing schizophrenia, it is crucial to have treatment options that work to reduce the risk of relapse ... About Schizophrenia ... Schizophrenia. www.who.int/news-room/fact-sheets/detail/schizophrenia.
Edit

significant positive effects for patients with schizophrenia

Bitchute 29 Oct 2021
Go to the source via the article link to view the video ....
Edit

Boehringer Ingelheim and King’s College London Join Forces to Progress New Therapeutic Concepts in Major Depressive Disorder and Schizophrenia

Algeria Times 28 Oct 2021
• The collaboration will produce a comprehensive clinical research program in major depressive disorder and schizophrenia, building upon Boehringer Ingelheim’s circuitry-based approach to precision psychiatry and further solidifies commitment to provide better treatments for people living with serious mental health conditions.
Edit

Mental Health Conditions Can Heighten Covid-19 Risk, C.D.C. Says

New York Times 28 Oct 2021
Tens of millions of Americans with depression, schizophrenia and other mental health disorders are now potentially eligible for a booster shot ... .
Edit

Boehringer Ingelheim and King's College London Join Forces to Progress New Therapeutic Concepts in Major Depressive Disorder and Schizophrenia

Canada Dot Com 27 Oct 2021
The collaboration will produce a comprehensive clinical research program in major depressive ...
Edit

Man With Schizophrenia Reported Missing In Downtown Los Angeles

CBS Sports 26 Oct 2021
LOS ANGELES (CBSLA) – Authorities sought the public’s help Monday to locate a 31-year-old man who suffers from schizophrenia and was last seen in downtown Los Angeles ... .
×